July 16, 2010 – High demand has led Positron Corp. to increase production of Attrius positron emission tomography (PET) scanner with its joint venture, Neusoft Positron Medical Systems, the company announced recently.

Facilitated by the increase in reimbursement for cardiac PET and an industry-wide movement to better and more efficient medical imaging, Positron’s Attrius has seen unprecedented interest and sales since being introduced last year. As a result of the recent sales, Positron has met its six-month projections and has to increase production earlier than previous estimations. Based on Positron’s current sales and a more robust pipeline, the company believes that it will surpass 2010 and 2011 targets of approximately 70 systems in the next 18 months.


Additional Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
Subscribe Now